• N/A
    Market Cap
  • -68.84%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
22.5M
-39.15%
37.0M
N/A
Cost of Revenue
3.7M
-16.66%
4.4M
N/A
Gross Profit
18.9M
-42.17%
32.7M
N/A
Sales and Marketing Expense
10.3M
+152.75%
4.1M
N/A
Research and Development Expense
-20.1M
+226.04%
-6.2M
N/A
Depreciation and Amortization Expense
1.1M
-3.08%
1.1M
N/A
Total Operating Expenses
44.5M
+156.74%
17.3M
N/A
Operating Profit
-25.6M
-267.36%
15.3M
N/A
Interest Income
301
-23.41%
393
N/A
Interest Expense
-354,341
-28.74%
-497,247
N/A
Interest Income and Expense and Net
-354,040
-28.74%
-496,854
N/A
Total Nonoperating Income and Expense
-100,195
-84.62%
-651,657
N/A
Income before Taxes
-26.4M
-287.23%
14.1M
N/A
Income Taxes
1.2M
-21.69%
1.5M
N/A
Extraordinary Items
0
N/A
0
N/A
Net Income
-27.3M
-316.52%
12.6M
N/A
Net Income from Continuing Operations Applicable to Common
-26.4M
-287.23%
14.1M
N/A
Basic EPS and Net Income
-0.98
-300.00%
0.49
N/A
Diluted EPS and Net Income
-0.98
-300.00%
0.49
N/A
Basic Weighted Average Shares
27.8M
+8.76%
25.6M
N/A
Diluted Weighted Average Shares
27.8M
+8.45%
25.6M
N/A
Balance Sheet
Cash and Cash Equivalents
178,321
-94.00%
3.0M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
178,321
-94.00%
3.0M
N/A
Total Current Assets
55.0M
-10.50%
61.4M
N/A
Accumulated Depreciation
5.9M
+28.90%
4.6M
N/A
Property and Plant and Equipment and Net
6.4M
-10.79%
7.1M
N/A
Total Long-Term Assets
14.7M
-10.97%
16.5M
N/A
Total Assets
69.7M
-10.60%
78.0M
N/A
Income Taxes Payable
3.1M
+7.83%
2.9M
N/A
Total Short-Term Debt
13.1M
-23.28%
17.0M
N/A
Total Current Liabilities
32.4M
-6.53%
34.6M
N/A
Total Long-Term Debt
6.1M
+76.80%
3.4M
N/A
Total Long-Term Liabilities
6.1M
+70.82%
3.6M
N/A
Total Liabilities
38.5M
+0.72%
38.2M
N/A
Retained Earnings
-515,415
-101.93%
26.8M
N/A
Total Stockholders Equity
31.4M
-20.91%
39.7M
N/A
Total Shares Outstanding
30.8M
+61,404.74%
50,000
N/A
Cash Flow
Cash from Operating Activities
-1.3M
-78.71%
-6.3M
N/A
Capital Expenditures
42,315
-98.52%
2.9M
N/A
Cash from Investing Activities
-42,315
-98.52%
-2.9M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
-1.4M
-113.00%
10.7M
N/A
Financials Ratio
Gross Margin
83.79%
N/A
N/A
N/A
Operating Margin
-113.73%
N/A
N/A
N/A
Return on Assets
-36.95%
N/A
N/A
N/A
Return on Equity
-76.81%
N/A
N/A
N/A
Revenue Growth
-39.15%
N/A
N/A
N/A
Current Ratio
1.70
N/A
N/A
N/A
Cash Ratio
0.006
N/A
N/A
N/A
Debt-to-Equity Ratio
0.61
N/A
N/A
N/A
Debt-to-Assets Ratio
0.27
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow